Glycovax-Ph-SLA-lg-scale-prod-N-Rel-25-02-25-V14

Glycovax Pharma Begins Large-Scale Commercial Production
of SLA adjuvant through an exclusive worldwide license with the
National Research Council of Canada (NRC)